Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,995 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

NCT02528214

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site Number 840022 Los Angeles, California, United States
  • Investigational Site Number 840014 Rolling Hills Estates, California, United States
  • Investigational Site Number 840002 St Louis, Missouri, United States
  • Investigational Site Number 840010 Pittsburgh, Pennsylvania, United States
View all 80 locations
View Trial Details
Completed

Feasibility Study of the Hemolung Respiratory Assist System (Germany)

NCT01021605

Conditions
Chronic Disease, Disease Attributes, Hypercapnic Respiratory Failure, COPD, ARDS, +8 more
Locations
  • Thoraxklinik am Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Ruhrlandklinik Das Lungenzentrum Essen-Heidhausen Abt.: Pneumologie Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Bonn Bonn, Germany
  • Klinik Donaustauf Donaustauf, Germany
View Trial Details
Completed

Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

NCT03003494

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Ospedale Generale Regionale "Miulli" Acquaviva Delle Fonti (BA), Italy
  • Azienda Ospedaliera G. Rummo Benevento, Italy
  • Casa di cura Mons. Calaciura Biancavilla, Italy
  • Ospedale Orlandi Bussolengo (VR), Italy
View all 28 locations
View Trial Details
Completed

OTIVACTO Spain Non Interventional Study

NCT02927795

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Centro de Salud Águilas Sur Aguilas (Murcia), Spain
  • Consultorio Médico de Albelda Albelda (Huesca), Spain
  • Centro de Salud Alcantarilla-Sangonera Alcantarilla (Murcia), Spain
  • Centro de Salud Alquerías Raal Alquerías (Murcia), Spain
View all 79 locations
View Trial Details
Completed

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

NCT01490632

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Monica, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miramar, Florida, United States
View all 35 locations
View Trial Details

Related conditions